Itolizumab for COVID-19
-
Biocon Gives Clarification on Clinical Study of Itolizumab for COVID-19 after Backlash
Bengaluru: On July 11, Biocon Limited announced that the Drugs Controller General of India approved its drug Itolizumab “for emergency…
Read More »